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The integration of medical data coming from multiple sources is important in clinical research. Amongst
others, it enables the discovery of appropriate subjects in patient-oriented research and the identiﬁcation
of innovative results in epidemiological studies. At the same time, the integration of medical data faces
signiﬁcant ethical and legal challenges that impose access constraints. Some of these issues can be
addressed by making available aggregated instead of raw record-level data. In many cases however, there
is still a need for controlling access even to the resulting aggregated data, e.g., due to data provider’s pol-
icies. In this paper we present the Linked Medical Data Access Control (LiMDAC) framework that capital-
izes on Linked Data technologies to enable controlling access to medical data across distributed sources
with diverse access constraints. The LiMDAC framework consists of three Linked Data models, namely the
LiMDAC metadata model, the LiMDAC user proﬁle model, and the LiMDAC access policy model. It also
includes an architecture that exploits these models. Based on the framework, a proof-of-concept platform
is developed and its performance and functionality are evaluated by employing two usage scenarios.
 2014 Elsevier Inc. All rights reserved.1. Introduction
Clinical research aims at ﬁnding new and better ways to under-
stand, diagnose, prevent, or treat a speciﬁc pathological process,
e.g., diseases or adverse events. It comprises three main categories:
(i) the patient-oriented research that involves human subjects; (ii)
the epidemiological and behavioral studies that examine the distri-
bution of disease and the factors that affect health; and (iii) the
outcomes and health services research that seeks to identify the
most effective and efﬁcient interventions, treatments, and services
[1].
Clinical research often requires the integration of medical data
coming from multiple datasets that are usually stored across mul-
tiple sources such as hospitals, clinical sites, research institutes and
pharmaceutical companies [2–5]. Medical data may contain sensi-
tive patient data such as demographics, diagnoses, and medication,
as well as radiology images, laboratory test results, doctors’ entries
and comments [6,7].
In patient-oriented research, the integration of multiple medi-
cal datasets enables the identiﬁcation of a sufﬁcient number of
subjects [8]. For example, clinical trial phase III, which assessesthe safety and the efﬁcacy of a studied treatment or drug, requires
large groups of people matching speciﬁc eligibility criteria that
cannot be found through a single clinical site. In epidemiological
studies, analysis of integrated datasets improves the statistical
power of results. For instance, studies of clinical effectiveness or
disease biology in rare diseases are only possible through multi-
center analyses [9]. The integration of multiple datasets also en-
ables better understanding of relationships between pathological
processes and risk factors, or between genotype and phenotype
[10,11]. For example, recent genome-wide association studies
identiﬁed 13 novel loci associated with systolic and diastolic blood
pressure as well as hypertension [12,13].
At the same time however, clinical researchers face technical
and interoperability [14], as well as ethical and legal [15], chal-
lenges in discovering and accessing scattered and heterogeneous
medical data. Although the former challenges have been addressed
by several standards [16,17], the latter still remain.
In order to overcome these ethical and legal challenges, the ap-
proach of aggregating data has been proposed and widely em-
ployed. According to this approach, only the counts of subjects
having speciﬁc characteristics are reported instead of raw record-
level data, guaranteeing in this way non-identiﬁcation and anony-
mization. Despite that, there is still need for controlling access
even to aggregated data, e.g., due to data providers’ policies. A
promising technology that facilitates data discovery and access at
a Web scale is Linked Data. Linked Data refers to ‘‘data published
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explicitly deﬁned, it is linked to other external datasets, and can in turn
be linked to from external datasets’’ [18]. Currently, the most prom-
ising implementation of Linked Data involves publishing struc-
tured data in RDF using URIs in contrast to the full-ﬂedged
Semantic Web vision focusing on the ontological level or inferenc-
ing [19].
The objective of this paper is to present the Linked Medical Data
Access Control (LiMDAC) framework that capitalizes on Linked
Data technologies to enable controlling access to medical data
across distributed sources with diverse access constraints. The
framework consists of (a) three Linked Data models, namely the
LiMDAC metadata model for describing aggregated medical data,
the LiMDAC user proﬁle model for describing medical data con-
sumers, and the LiMDAC access policy model, and (b) an architec-
ture that exploits and orchestrates the three models to enable
controlling access to medical data. From a technological perspec-
tive, the framework is validated using a proof-of-concept platform
that is developed for that purpose.
The remaining of the paper is organized as follows. In Section 2,
we provide background knowledge that is necessary for scoping
and presenting our work. Section 3 presents the state-of-the-art
regarding (a) existing solutions for controlling access to medical
data and (b) the use of Linked Data technologies in medical data
and for access control. Section 4 describes the proposed LiMDAC
framework while Section 5 illustrates a proof-of-concept imple-
mentation of the LiMDAC framework. Finally, in Section 6 the re-
sults are discussed and in Section 7 conclusions are drawn.2. Access constraints
Ethical and legal challenges related to medical data mainly de-
rive from (a) strict regulations that protect personal data and pre-
vent patient re-identiﬁcation by any means [20], (b) agreements
that are speciﬁed in consent forms, e.g., patients approve sharing
their data only in certain clinical studies [21], and (c) policies of
stakeholders owing the data e.g., pharmaceutical companies do
not contribute to a clinical research led by competitors, or physi-
cians exclude data derived from studies in progress [22–24].
In general, ethical and legal challenges impose access con-
straints that can be categorized as follows [25,26]:
 Secrecy: Ensures the privacy of patients and the conﬁdentiality
of medical data preventing unauthorized disclosures of
information.
 Integrity: Ensures the integrity of medical data and prevents
unauthorized or improper modiﬁcations of data.
 Availability: Ensures the availability of medical data only to
authorized persons and prevents the unauthorized or unin-
tended withholding of data.
In order to overcome secrecy and integrity constraints, the ap-
proach of aggregating data has been proposed. Aggregated data in-
cludes only counts of patients having speciﬁc characteristics
instead of raw record-level information. Aggregated data is usually
structured in the form of multi-dimensional data cubes [27,28]. In
this way, non-identiﬁcation and anonymization are ensured while
the original data remain safe from any modiﬁcations. Despite that,
there is still a need for controlling access to aggregated data, e.g.,
due to data provider’s policies, and thus availability constraints call
for appropriate solutions [29].
In order to elaborate on availability constraints, a patient-ori-
ented research and an epidemiological study scenario are de-
scribed below.2.1. Patient-oriented research
In patient-oriented research, clinical researchers search for sub-
jects that meet certain eligibility criteria related to a clinical study.
Initially they identify possible data providers and ask them
whether data of relevant subjects is included in their patients’
database. Data providers having such data and wishing to partici-
pate to the speciﬁc clinical study have to perform some intensive
tasks. First, they check whether the identiﬁed subjects can be in-
cluded according to the study’s eligibility criteria. Then, they match
the eligible subjects with the patients’ consent forms to identify if
they can be enrolled to the speciﬁc trial. Finally, they conﬁrm that
access to the patient data is permitted without violating any access
constraints, e.g., when subjects have been recruited for a different
trial. If the number of eligible patients is not sufﬁcient, clinical
researchers seek for additional subjects from other sources to meet
the recruitment target.
2.2. Epidemiological study
In epidemiological studies, clinical researchers perform statisti-
cal analyses of medical data in order to conduct secondary clinical
research and thus, identify risk factors inﬂuencing the occurrence
of a pathological process. In order to have accurate and statistically
signiﬁcant results, they need a large number of medical data. To
this end, they identify possible data providers and ask for relevant
data they can access without violating any access constraints. Data
providers wishing to contribute to the speciﬁc clinical research
have to perform some intensive tasks. First, they modify their data
in order to ensure that their data will be transferred in an anony-
mized and non-identiﬁable form. To achieve this, they delete all
references to the subject and create aggregated data. Data provid-
ers conﬁrm that access to the data is permitted without violating
any policies and provide the data e.g., data that is used for studies
in progress.
In addition to these scenarios, we interviewed stakeholders
working in organizations that participate in the EU funded FP7 Lin-
ked2Safety project [30]. In particular, we interviewed ﬁve clinical
researchers, one data manager and three clinical study managers
coming from three healthcare organizations maintaining and using
medical data for clinical research, namely the Institute of Neurol-
ogy and Genetics in Cyprus, the Lausanne University Hospital,
and ZEINCRO Hellas S.A., a private Contract Research Organisation
in Greece. This exercise resulted in a list of user requirements that
are related to availability constraints. This list is presented in
Appendix A.
These scenarios and requirements enable us to identify that two
abstract roles related to medical data management are important in
clinical research. The data provider creates and keeps medical data
regarding patient-speciﬁc information in order to organize pa-
tients’ treatment, or conduct a clinical research. The data consumer
discovers subjects meeting certain eligibility criteria for a patient-
oriented research, or medical data to perform an epidemiological
study.
In addition, these scenarios and requirements enable us to come
up with an abstract process that delineates clinical research and
consists of the following steps:
1. Data provider modiﬁes and aggregates data in order to ensure
anonymity and non-identiﬁcation.
2. Data consumer searches for data providers.
3. Data consumer asks data provider for certain data.
4. Data provider checks whether the requested data is available.
5. Data provider checks whether data consumer is allowed to
access the data according to some access constraint policies.
6. Data consumer receives the data.
E. Kamateri et al. / Journal of Biomedical Informatics 50 (2014) 213–225 2153. State of the art
3.1. Access control of medical data
Two different approaches to discover and access medical data
from multiple data sources have been proposed: centralized and
distributed [3]. The centralized approach enables access to medical
data that has been transferred in centralized repositories. Alterna-
tively, distributed medical data networks enable discovery of med-
ical data in their original, disparate locations.
Several frameworks consisting of processes, data models and
software tools have been recently developed in order to enable
medical data sharing and reuse [31]. For example, the Informatics
for Integrating Biology and the Bedside (i2b2) [32,33] open source
platform and software implementation allows clinical researchers
to search across multiple i2b2 sites, ﬁnd sets of interesting patients,
and reuse medical data while preserving patient privacy and ensur-
ing data integrity. While i2b2 created an analytic platform for a
single clinical data repository, the Shared Pathology Information
Network (SPIN) [34] has tackled the problem of cross-institution
data sharing across a peer-to-peer network, in which each partici-
pating institution maintains autonomy and control of its own data.
The Shared Health Research Information Network’s (SHRINE)
[35,36] was built upon i2b2 and SPIN to enable investigators to
search the electronic health records of patients across multiple
independent sites. In the same context, the Cross-Institutional
Clinical Translational Research (CICTR) [8] framework also ex-
tended i2b2 in order to enable federated queries across i2b2 sites.
In particular, implementations of these two frameworks allow que-
rying distributed hospitals and display aggregate counts of the
number of matching patients. The Biomedical Informatics Research
Network (BIRN) [37] aggregates imaging, clinical and behavioral
data from multiple independent sites using a mediator that re-
submits user queries to the relevant sites and aggregates results.
The Service-Oriented Interoperability Framework (SIF) [38] targets
heterogeneous data sources and employs Web Services standards
(e.g., SOAP) to query JDBC databases. In this case users should be
aware of all data models in order to form appropriate queries. The
Federated Utah Research & Translational Health e-Repository (FUR-
THeR) [39] is also based on Service Oriented Architecture and em-
ploys Web Services standards in order to perform federated
queries across distributed data sources. Finally, the integrating Data
for Analysis, anonymization, and SHaring (iDASH) [40] framework
covers many aspects of medical data reuse including annotation,
compression, anonymization, information extraction from text,
sharing in a privacy-preserving manner, and integration.3.2. Linked medical data
Linked Data is an approach for accessing and connecting data
using open Web standards. The Linked Data publishing process
[41,42] usually begins with existing, structured data in various for-
mats (CSV, relational data, XML, etc.), which are converted to RDF.
The publication is based on a Linked Data model that can be created
either by devising a new local schema (in RDF Schema, OWL, etc.),
or by reusing existing, widespread vocabularies (such as FOAF [43],
Dublin Core [44], and SKOS [45]). Thereafter, URIs are assigned to
the items in the dataset on the instance level and interlinks are
established with other datasets. There are typically two types of
links that can be established, namely owl:sameAs used to link URI
aliases and other, domain-speciﬁc RDF links such as foaf:knows
and dc:author.
The importance of publishing medical data as Linked Data be-
comes apparent in the case that we reuse widely used ontologies
or linked datasets. For example, the International Classiﬁcation ofDiseases-11 ontology [46] classiﬁes diseases and other health
problems, including signs, symptoms, abnormal ﬁndings, etc. In
addition, the Experimental Factor Ontology (EFO) [47] combines
parts of several biological ontologies, such as anatomy, disease
and chemical compounds, to annotate experimental variables. Fur-
thermore, an increasing amount of life science datasets are becom-
ing available as linked data. UniProt is a database of protein
sequence [48], Reactome describes biological pathways [49],
ChEMBL contains bioactive drug-like small molecules [50], ChemS-
pider includes chemical compounds [51], and WikiPathways de-
scribes pathways [52]. The reuse of such ontologies and linked
datasets enables the disambiguation of concepts referring to the
same entity, as well as the enrichment of medical data with data
coming from disparate sources.
The RDF Data Cube vocabulary (qb) is a Linked Data model that
deﬁnes how to structure multi-dimensional data using RDF [53].
It is of vital importance in linked medical data because it can be
used to publish the aggregated data that clinical researchers pro-
duce. According to the vocabulary, a data cube (qb:Dataset) consists
of observations (qb:Observation) that are characterized by dimen-
sions (qb:DimensionProperty), measures (qb:MeasureProperty) and
possibly by additional attributes (qb:AttributeProperty). Speciﬁcally,
the dimension deﬁnes the characteristics of the observed proper-
ties (e.g., gender, BMI, received medication and weight), the mea-
sure describes what has been measured (e.g., cases) and the
attribute represents how the observations are expressed (e.g.,
units, status, etc.) The possible values for each dimension are taken
from a code list. A code list is a controlled vocabulary such as a list
of diseases, or possible age groups.
At the same time, several research efforts have been made so far
to control access in data published as Linked Data [54]. Initially, ac-
cess policies were deﬁned for the entire RDF ﬁle stored on a web
server [55,56]. Thereafter, it was attempted to apply access policies
on parts of the RDF graph [57–62]. In order to achieve this, the pro-
posed access control frameworks deﬁne parts of the RDF graph on
which access can be allowed (or denied). These parts are identiﬁed
by specifying RDF patterns. Whereas the above approaches have
primarily focused on RDF patterns, Costabello et al. [63] and Sacco
et al. [64] propose access control ontologies over Linked Data. They
both employ the SPARQL ASK to determine whether the requester
is allowed, or not to access the requested resource. In general, the
ASK query form can be used to test whether a query pattern has a
solution and returns whether the solution exists. An important is-
sue that may arise is the increase of the overhead produced by
evaluating policies in every RDF triple [65].4. The linked medical data access control framework
The proposed Linked Medical Data Access Control (LiMDAC)
framework consists of the following:
a. Three Linked Data models, namely the LiMDAC metadata
model, the LiMDAC user proﬁle model and the LiMDAC
access policy model.
b. An architecture that exploits and orchestrates the three
models to enable controlling access to medical data.
The framework aims at supporting the abstract process of data
management in clinical research presented in Section 2. In partic-
ular, the steps of the process supported by the LiMDAC framework,
along with a mapping to those steps presented in Section 2, are de-
picted in Table 1. In this table we assume that a platform has been
implemented based on the LiMDAC architecture.
The rest of this section is structured according to the main parts
of the process and framework. In particular, Section 4.1 presents
Table 1
Abstract clinical research process supported in the LiMDAC framework.
Existing abstract process Abstract process in the LiMDAC framework
Setup phase
1. Data provider modiﬁes and aggregates data in order to ensure anonymity and
non-identiﬁcation
1. (This is not supported by the current version of the LiMDAC framework)
 Data providers publish aggregated data as Linked Data and they use the LiM-
DAC metadata model to describe them
 Data providers deﬁne access constraints using the LiMDAC access policy
model
 Data consumers create proﬁles based on the LiMDAC user proﬁle model
Access phase
2. Data consumer searches for data providers 2. Data consumer searches for data providers’ SPARQL endpoints through the
LiMDAC platform
3. Data consumer asks data provider for certain data 3. Data consumer search for suitable data based on the LiMDAC metadata model
4. Data provider checks whether the requested data is available 4. The LiMDAC platform checks whether the providers’ datasets include suitable
data
5. Data provider checks whether data consumer is allowed to access the data
according to some access constraint policies
5. The LiMDAC platform checks data consumer’s proﬁle against the available
access policies
6. Data consumer receives the data. 6. Data consumer receives suitable data through the LiMDAC platform.
Table 2
Children’s obesity data cube coming from a data provider.
Disease Hypothyroidism Diabetes . . .
BMI 15 16 17 . . . 15 16 17 . . . 15 16 17 . . .
Age
2 22 22 23 12 23 11
3 23 22 23 20 23 12
4 22 22 24 30 24 22
. . .
216 E. Kamateri et al. / Journal of Biomedical Informatics 50 (2014) 213–225how aggregated medical data should be developed and published
as Linked Data. This corresponds to the setup phase of Table 1
and is an essential prerequisite for the LiMDAC framework. We
note that this is presented here only for clarity. The processes,
technologies and tools for performing these tasks are outside the
scope of this paper, as they are well documented in the relevant lit-
erature, e.g., [27,28]. Section 4.2 describes the LiMDAC metadata
model, while Section 4.3 presents the LiMDAC user proﬁle model.
Section 4.4 elaborates on the LiMDAC access policy model and Sec-
tion 4.5 describes an architecture that exploits these three models.
In order to enhance clarity, we present a research study about
childhood obesity [66]. According to the study, six paediatric aca-
demic health sites from different regions of the United States have
participated in a clinical research related to children’s obesity. The
dataset maintained by each site involves records about children
between 2 and 17 years old. For each child, the health sites store
information about the age and the Body Mass Index (BMI). More-
over, the health sites have detected groups of conditions that most
commonly co-occur with obesity including hypertension, hyperlip-
idaemia as well as other rare disorders such as acute leukaemia,
multiple sclerosis, and chromosomal anomalies. In this paper, we
use the background scenario of this study in order to present our
results. We should, however, underline that we have used dummy
and not real data from the study.1 http://sdmx.org/.4.1. Linked medical data cubes
Based on the obesity example, Table 2 depicts part of a trun-
cated dummy data cube provided by one of the sites.
Fig. 1 presents the RDF graph produced from the data shown in
Table 2. The graph is modelled based on the RDF data cube vocab-
ulary. In particular, it describes the data structure deﬁnition, along
with two observations. The SKOS concept collection is used to indi-
cate a set of disease concepts. Fig. 1 also presents the links thathave been established between concepts and external vocabular-
ies. It is apparent that ‘‘ex:disease’’ is linked to the concept
‘‘EFO:disease’’ from the EFO ontology that has the same meaning.
The concept ‘‘EFO:body mass index’’ can be reused for the BMI
dimension. Moreover, the measurement of frequencies and the
age dimension can be expressed using the Statistical Data and
Metadata eXchange standard (SDMX)1 which is used to publish sta-
tistical data on the web.
We repeat here that medical data is transformed in this format
during the setup phase shown in Table 1, is a prerequisite for
employing the LiMDAC framework, and is not further elaborated
in this paper.4.2. The LiMDAC metadata model
The LiDMAC metadata model facilitates the improved descrip-
tion of linked data cubes. Metadata enable data providers to ex-
press richer access constraints and data consumers to perform
more expressive search queries.
The RDF data cube vocabulary includes the qb:DataStructureDef-
inition concept which deﬁnes metadata related to cube structure.
These metadata include the dimensions of the data cube, along
with the values that are measured. However, additional metadata
are needed to provide information about the clinical study (e.g., ti-
tle, purpose, duration, location, subject, responsible personnel for
conducting the clinical study, etc.) and the aggregation process
that has been followed. These metadata were extracted from the
requirements described in Section 2 and presented in Appendix A.
Table 3 presents the mapping between the requirements and
the concepts extracted for describing medical data cubes. Based
on these concepts, a conceptual model has been created, which is
depicted in Fig. 2.
Fig. 1. RDF graph of children’s obesity data cube.
Table 3
Concepts of the LiMDAC metadata model as elicited from user requirements.
Concepts Data Study Agent Role Variable PeriodOfTime Location
Requirements
R1
p p
R2
p p p
R3
p p
R3a
p
R3b
p
R3c
p
R3d
p p p
R3e
p p p
R3f
p p p
R3g
p p p
R3h
p p
R3i
p p p
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data vocabulary. Since the model follows the linked-data princi-
ples, it reuses concepts from existing vocabularies instead of deﬁn-
ing new ones. In particular, the following popular linked data
vocabularies are exploited:
 The DDI Discovery Vocabulary [67] that describes research and
survey datasets on the Web.
 The DCMI Metadata Terms vocabulary [44] that is a speciﬁca-
tion of all metadata terms used to describe a resource.
 The FOAF vocabulary [43] that describes people and their
relationships.
 The SKOS vocabulary [45] that is used to deﬁne classiﬁcations.In order to describe the proposed metadata model, we use the
Study class (disco:Study) as an entry point. A Study represents the
process by which a dataset was collected. It may contain a set of
literal properties that provide information about the title (dcterm-
s:title), the purpose (disco:purpose), and other high-level informa-
tion. In addition, a Study includes object properties such as the
sponsor of the Study (disco:fundedBy), and other afﬁliations such
as the creator, the contributor and the publisher (dcterms:creator,
dcterms:publisher, dcterms:contributor). They all are foaf:Agents,
which can be either foaf:Persons or org:Organizations whose
members are foaf:Persons. Moreover, we can use the subject, the
temporal and the spatial properties (disco: subject, dcterms:tempo-
ral, dcterms:spatial) to describe the respective coverage of studies.
Fig. 2. The LiMDAC metadata conceptual model.
Fig. 3. The LiMDAC metadata linked data model.
218 E. Kamateri et al. / Journal of Biomedical Informatics 50 (2014) 213–225For time periods, start (disco:startDate) and end dates (disco:end-
Date) can be also attached.
The outcome of a Study is a raw record-level dataset (disco:Log-
icalDataSet) that may point to multiple variables (disco:Variable).
The LogicalDataset contains a property disco:aggregation that
indicates that a data cube (qb:Dataset) was derived by tabulating
a LogicalDataset. Furthermore, the Study/LogicalDataset has a
DataFile (disco:DataFile) that is the distributed ﬁle holding that
data.
In the example of childhood obesity, the Children’s Hospital of
Colorado is the creator of the study that is titled ‘‘Multi-institu-
tional study to access childhood obesity’’ and its purpose is to asso-
ciate several health conditions with childhood obesity. Michael G.
Kahn is the principal investigator of the study as well as responsi-
ble person for creating the data cubes transforming the produced
medical data in an aggregated form and publishing them as linked
data. The study was funded by the Agency for Healthcare Research
and Quality (AHRQ) and run from January 2007 to December 2008.
Taking into account all this information, the Children’s Hospital
of Colorado enriches the linked data cube derived from this study
with the following LiMDAC metadata as shown in Fig. 4.4.3. The LiMDAC user proﬁle model
The LiMDAC user proﬁle model is used to describe data con-
sumers. This model is exploited by data providers to deﬁne their
access constraints and by data consumers to describe their user
proﬁles. The LiMDAC user proﬁle model should be in alignment
with the requirements expressed by clinical research stakeholders
(Appendix A). Table 4 presents the mapping between users
requirements and the identiﬁed concepts that are used in the
model (Fig. 5).
Fig. 6 shows the proposed LiMDAC user proﬁle model in terms
of a linked data vocabulary. Again, the model capitalizes on popu-
lar linked data vocabularies by reusing existing concepts instead of
deﬁning new ones. In particular, it capitalizes on the following
linked data vocabularies:
 The FOAF vocabulary [43] that deﬁnes the agent.
 The Organization vocabulary [68] that is used to describe orga-
nizational structures.
 The PROV Ontology [69] that is used to model provenance
information.
Fig. 4. Metadata of children’s obesity data cube.
Table 4
Concepts of the LiMDAC user proﬁle model as elicited from user requirements.
Concepts Person Organization Position Location Activity Role
Requirements
R13
p
R14
p p
R15
p
R16
p p
R16a
p
R16b
p
R16c
p p
R16d
p p
R17
p p
R17a
p
R17b
p
R17c
p
R17d
p p
Fig. 5. The LiMDAC user pro
E. Kamateri et al. / Journal of Biomedical Informatics 50 (2014) 213–225 219 Finally, the SKOS vocabulary [45] that is used to deﬁne
classiﬁcations.
We use the Organization vocabulary to deﬁne the Organization
(org:Organization) that a data consumer works for (org:memberOf).
The class org:Post represents the position that the data consumer
holds in the Organization. The org:Site denotes the ofﬁce or other
premise at which the Organization is located. In addition, the Site
uses the property org:siteAddress to indicate the address of the Site.
The SKOS vocabulary is used to deﬁne the classiﬁcation of the
Organization within some classiﬁcation scheme (org:classiﬁcation).
Furthermore, the PROV concept prov:Activity associates an agent
(prov:Agent,) with an action/activity that he plans, or is responsible
to conduct on the extracted data.
In the example of childhood obesity, we could consider two
clinical researchers, researcher A and researcher B.ﬁle conceptual model.
Fig. 6. User metadata model.
220 E. Kamateri et al. / Journal of Biomedical Informatics 50 (2014) 213–225Researcher A works as a biologist. His current occupation is
principal trial investigator in AHRQ while his latest research inter-
ests are related to the effects of the obesity in children’s life. Re-
searcher A has decided to undertake a clinical research related to
the effectiveness of a new treatment to children’ obesity for chil-
dren presenting diabetes. To this end, he needs a sufﬁcient number
of subjects aged under 18 and diagnosed with diabetes (patient-re-
lated research).
Researcher Bworks as an endocrinologist in the Children’s Hos-
pital of Philadelphia. His research interests are related to health
habits. Recently, researcher B has started an epidemiological study
about health habits and their effects on children’s health. In order
to receive statistically signiﬁcant results from the statistical analy-
ses, he needs a sufﬁcient amount of medical data derived from
youth patients aged under 18 and containing information about
BMI, regular exercise and/or vegetable consumption (epidemiolog-
ical study).
Taking into account all this information, the user proﬁles of the
two data consumers are presented in Fig. 7.Fig. 7. User4.4. The LiMDAC access policy model
Access policies deﬁne the data to be protected and to whom ac-
cess is granted or denied. Thus, each access policy consists of two
parts. The ﬁrst includes the metadata proﬁle of the medical data
that will be protected and the second the proﬁle of data consumers
that are allowed (or not) to have access to the data.
In the LiMDAC framework we adopt a simpliﬁed access policy
approach that enables us to assign access policies dynamically on
linked data cubes sharing common characteristics. In particular,
the LiMDAC access policy model speciﬁes (a) an RDF pattern
based on the LiMDAC metadata model to limit the application
of policies only to data cubes annotated with those metadata
and (b) a user pattern based on the LiMDAC user proﬁle model
to give the access permission only to users described with those
attributes.
Fig. 8 depicts the LiMDAC access policy linked data model that
consists of the following concepts:proﬁles.
Fig. 8. Access policy model.
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applied. The dataset is usually a store containing all linked data
cubes of a provider.
 The Data Cube Space: It describes the data cubes, in which the
access policy applies. This is achieved through an RDF pattern
based on the LiMDAC metadata model that should be satisﬁed
by the metadata of a data cube. If the metadata contain this pat-
tern then the access policy is applied to the data cube.
 The Access Space: It deﬁnes the data consumers for which the
access policy applies. This is achieved through an RDF pattern
based on the LiMDAC user proﬁle model that speciﬁes a user
proﬁle.
 The Access Control Privilege: It deﬁnes both types of permissions
(i.e., grantAccess/denyAccess) and permitted operations (read/
write/update). We deﬁne it as a subtype of the acl:Access.
In the example of childhood obesity, each paediatric hospital
serves as an individual data provider maintaining in a local repos-
itory a large number of linked data cubes coming from various clin-
ical researches. Based on the proposed access policy model, each
data provider creates access policies to make available the linked
data cubes only to authorized data consumers and under speciﬁc
conditions. Consider the case of the Children’s Hospital of Colo-
rado. Using the proposed access policy model, it creates the
following access policies:Fig. 9. Example of1. The data cubes derived from the childhood obesity study and
sponsored by AHRQ can be accessed by any user working at
AHRQ.
2. The data cubes having in their structure the BMI dimension are
authorized for access to data consumers working at the Chil-
dren’s Hospital of Philadelphia and being endocrinologists.
Fig. 9 presents the RDF representation of the second access
policy.4.5. The LiMDAC architecture
Fig. 10 illustrates an architecture that exploits and orchestrates
the three LiMDAC models to enable controlling access to medical
data. Apart from the LiMDAC models, the architecture includes
an Authorization Mechanism module and an Authorization Inter-
face module.
The Authorization Interface lies between data consumers and
providers. It enables data consumers to (i) create user proﬁles
based on the LiMDAC user proﬁle model and (ii) search for distrib-
uted medical data. The data consumer deﬁnes the purpose of
accessing medical data being either patient-oriented research or
epidemiological study. The search criteria are based on the dimen-
sions of the data cubes that are stored in the distributed RDF dataaccess policy.
Table 5
Complex and simple queries.
Complex query example Simple query example
SELECT ?diabetes ?bmi ?hyper SELECT ?cube
WHERE { WHERE {
?cube qb:structure ?struct. ?cube qb:structure ?struct.
?struct qb:component ?comp. ?struct qb:component ?comp.
?comp qb:dimension :Diabetes. ?comp qb:dimension :Diabetes.
Fig. 10. The LiMDAC architecture.
222 E. Kamateri et al. / Journal of Biomedical Informatics 50 (2014) 213–225stores. Next to each search criteria there is a ﬁeld for selecting its
value from a drop-down list of available codes.
Moreover, the Authorization Interface translates data consum-
ers’ queries into SPARQL queries and passes them onto the Autho-
rization Mechanism. Initially the Authorization Mechanism
retrieves the access policies from distributed data providers.
Thereafter, the Authorization Mechanism checks whether the pro-
ﬁle of the data consumer matches the user proﬁle deﬁned by each
access policy. In case of success, the Authorization Mechanism cre-
ates and sends SPARQL queries to distributed data providers. The
queries search for data that match both the data consumer’s query
and the satisﬁed access policies. In case of success, the resulted
datasets are returned to the data consumer via the Authorization
Interface.
The result of this process is either (i) (for patient-oriented re-
search purposes) the number of patients meeting speciﬁc criteria,
along with the name of the data provider publishing these data,
or (ii) (for epidemiological studies purposes) the respective linked
data cubes.
5. Proof-of-concept implementation and evaluation of the
platform
Based on the framework a proof-of-concept platform is devel-
oped and its functionality and performance are evaluated based
on two usage scenarios. The platform implements the Authoriza-
tion Mechanism and the Authorization Interface and exploits the
LiMDAC models. For its development we used the Jena
Framework.2
Following on the childhood obesity example, we consider that
there are four distributed data providers, each corresponding to a
different hospital. Each data provider stores linked data cubes pro-
duced in the course of different clinical studies (including the
childhood obesity example). Data providers also store metadata
and access policies for the cubes based on the LiMDAC metadata
and access policy models respectively. To emulate this setting,
we have used four distributed RDF data stores (implemented using
a Fuseki3 SPARQL server – part of the Jena Framework). A total of
120,000 linked data cubes are stored in each site. Each cube is struc-
tured based on 3 out of 10 dimensions that have been selected for
each clinical study. We use around 40 dimensions in total with each
receiving values from a pre-deﬁned coded list. Moreover, there exist
around 1.5 million triples expressing data cubes’ metadata that will
be searched by access policies.
In order to evaluate the platform we investigate two usage
scenarios. In the example of childhood obesity, researcher A (as2 http://jena.apache.org.
3 http://jena.apache.org/documentation/serving_data/.deﬁned in Section 4.3) needs medical data for patient-oriented re-
search (purpose) and selects the age dimension with value smaller
than 18 and the diabetes dimension. On the other hand, researcher
B needs medical data for epidemiological purposes and selects the
BMI, regular_exercise, vegetable_consumption and age dimen-
sions. In the value ﬁeld of the age dimension he indicates smaller
than 18 so that to investigate effects of health habits in young
people.
In the ﬁrst scenario, the system returns the number of subjects
meeting the speciﬁed criteria. Speciﬁcally, Researcher A is now
provided access to data derived from the childhood obesity study,
which his organization has funded.
In the second scenario, the system returns data cubes meeting
all speciﬁed criteria. We assume that this data comes from the
Children’s Hospital of Philadelphia and the Children’s Hospital of
Colorado. Researcher B works at the Children’s Hospital of Phila-
delphia, thus he is provided access to data coming from his organi-
zation. Moreover, he is provided access to data coming from the
Children’s Hospital of Colorado, since the Children’s Hospital of
Colorado has deﬁned a special access policy so as endocrinologists
coming from the Children’s Hospital of Philadelphia are permitted
access to data cubes related to BMI.
In order to evaluate the proof-of-concept platform, we per-
formed functionality, as well as performance and scalability, test-
ing based on two usage scenarios. In the functionality evaluation
testing, we validated and veriﬁed that all requirements are imple-
mented by the LiMDAC framework and the proof-of-concept
platform.
In order to evaluate the performance and scalability of the plat-
form, we have conducted two sets of experiments measuring the
response time. At each running, we have executed a complex (3
search criteria) and a simple (1 search criteria) user query. Table 5
presents an example of these queries. The main difference between
them is the number of dimensions requested. In our example,
diabetes, BMI and hypertension dimensions are requested in the
complex query while diabetes is requested in the simple one:
At the ﬁrst experimental setting (Table 6), each provider has
1000 access policies (we assume that 10% of the access policies?comp qb:dimension :Hypothyroidism. }
?comp qb:dimension :BMI.
}
Table 6
First experimental setting with 1000 access policies per provider.
#Cubes Simple query time (ms) Complex query time (ms)
1200 832 119
12,000 3816 262
120,000 23,249 657
Table 7
Second experimental setting with 120,000 cubes per provider.
#Access policies Simple query time (ms) Complex query time (ms)
10 180 150
50 1672 297
100 2117 319
1000 23,249 657
5000 562,141 5438
10,000 1,547,029 12,239
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1200, 12,000 and 120,000 cubes per provider. The response time
varies from 1 s to 23 s for the simple user query while for the com-
plex query the response time are much sorter (vary from 0.1 s to
0.6 s). The more search criteria are used the less cubes are matched
and thus, the quicker the response is. At the second experimental
setting (Table 7), the number of cubes is constant, namely
120,000. Here, the variable parameter is the number of access pol-
icies per provider. We repeated the measurement for 10, 50, 100,
1000, 5000 and 10,000 access policies per provider (assuming that
10% of the access policies are satisﬁed). Again at each case a simple
and a complex user query are executed. For the simple query the
response times are between 0.1 s and 23 s for realistic scenarios
until 1000 access policies, while the response time increases signif-
icantly as the access policies increase to simulate a web scale. For
the complex query the response times are between 0.1 s and 0.3 s
for realistic scenarios (i.e., until 1000 access policies) while the
response time reaches 5 s and 12 s for imaginary scenarios that
simulate a web scale (5000 and 10,000 access policies).
Based on the performance evaluation results, we observe that
the authorization mechanism is more sensitive to the number of
available access policies than to the number of available cubes.
At a real word scenario, it is expected to have a huge number of
cubes but the number of policies is not expected to be so high.
Based on that, we conclude that the proposed approach is expected
to work efﬁciently for web scale data.
6. Discussion
Several frameworks have been recently proposed to enable
sharing and reuse of medical data. These frameworks consist of
data models, processes, architectures, and software tools to ad-
dress various challenges of the data value chain, including ethical
and legal ones. These challenges impose access constraints that
are related to (a) the privacy of patients, (b) the integrity of data,
and (c) the availability of data to authorized only persons.
Although existing frameworks provide adequate solutions to the
ﬁrst two constraints, they usually follow simple approaches to
the latter type of constraints. For example, a common manner to
grant access to authorized users is through a static list of IP ad-
dresses or particular people.
In this paper, we introduced the Linked Medical Data Access
Control (LiMDAC) framework that capitalizes on Linked Data tech-
nologies to enable controlling access to linked aggregated medical
data across distributed sources with diverse access constraints.
Although, the main focus of LiMDAC is access control in a
Web-based environment, it caters for all diverse requirements of
medical data sharing.Medical data sharing frameworks usually employ the creation
of new data out of the original medical records in order to en-
sure data integrity. For example, in the i2b2 framework a copy
of the medical record is created and thus investigators are free
to ‘‘clean’’ and manipulate it for their own purposes with other
i2b2 software. These frameworks also employ techniques that
prevent unauthorized disclosure of patients’ information or iden-
tity. For example, a popular technique concerns returning aggre-
gate numbers of patients that satisfy a query to the record-level
medical data. In LiMDAC, data cubes that contain aggregate
numbers of patients are created from the actual medical data
in order to ensure both the privacy of the patients and the integ-
rity of the data. Although the creation of the data cubes is out of
the scope of the current LiMDAC version, the details of creating
and querying cubes in a linked data environment are described.
The scope of the existing frameworks ranges from single data
repositories to multiple distributed data sources inside an institu-
tion or at a cross-institutional setting. A suitable data model is crit-
ical in these cases so that medical record data and clinical trial data
can ﬁt together and thus diseases, genes, and outcomes can be re-
lated to each other. For example, the i2b2 ‘‘star schema’’ data mod-
el is used to instantiate at a project level the raw medical record
data. In the case of LiMDAC the RDF data cube vocabulary, which
is a W3C standard, is used to model the aggregated data. In addi-
tion, the adoption of the Linked Data paradigm enables reuse of
existing widely used vocabularies, datasets and code lists and thus
maximizes interoperability and alleviates the burden of semantic
alignment. This enables users of LiMDAC to perform queries in
multiple sites without having to be aware of the underlying sche-
ma of the other sites.
The majority of recent frameworks is based on a Service
Oriented Architecture and employ Web Services standards such
as SOAP protocol (e.g., in FURTHeR and i2b2) and paradigms such
as the Enterprise Service Bus (e.g., in iDASH framework). LiMDAC
is to the best of our knowledge the ﬁrst framework that adopts
the Linked Data paradigm to develop the underlying infrastructure
for sharing and reusing medical data. This will enable the easy
integration of medical data with other data on the Web (both
medical and third party data e.g., government data). This is
expected to enhance the possibility to gain innovative insights in
epidemiological studies.
Although several Linked Data access control frameworks have
been recently proposed, they all suffer from several shortcomings
when applied to RDF data cubes that represent aggregated medical
data. Medical data providers assign access constraints to cubes,
which are frequently updated, even once per week. So, there is a
need to assign access constraints dynamically based on domain
speciﬁc metadata. However, current Linked Data access control
frameworks do not support this need. Moreover, most of these
approaches restrict parts of the RDF graph having speciﬁc RDF
characteristics (e.g., triples containing a particular property), or
associate access policies to speciﬁc RDF data. An RDF data cube
can be considered as a small RDF graph made up of many triples.
Thus, access policies should apply on the data cube granularity le-
vel and access should be restricted based on cubes’ metadata in-
stead of RDF properties. LiMDAC satisﬁes these requirements by
employing the SPARQL ASK form in cubes’ metadata. It is also
important to mention that the LiMDAC framework has been pro-
posed as a simpliﬁed solution to address availability constrains
on linked medical data cubes.
From a technical perspective, the results of our initial perfor-
mance evaluation are promising, as they show only a small in-
crease in query processing time and a linear increase as the
number of data cubes and satisﬁed access policies grows. A signif-
icant delay has been noticed for simple queries only when the
number of access policies exceeds a speciﬁc level (5000 and
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views conducted with clinical stakeholders for extracting require-
ments about availability constraints. Indeed, they suggested that
an average of 5–20 access policies will be created for each dataset
of cubes.
7. Conclusion
In this paper, we introduced the Linked Medical Data Access
Control (LiMDAC) framework that capitalizes on Linked Data tech-
nologies to enable controlling access to linked aggregated medical
data across distributed sources with diverse access constraints.
LiMDAC consists of three Linked Data models, namely the LiMDAC
metadata model for describing medical data, the LiMDAC user pro-
ﬁle model for describing data consumers, and the LiMDAC access
policy model for medical data. It also includes an architecture that
exploits these models. Based on the framework, we developed a
proof-of-concept platform and evaluated its functionality and
performance by employing two usage scenarios.
The LiMDAC framework confronts the problemsof current linked
data access control frameworks providing granularity in data cube
structure layer. In particular, it exploits data cubes’ metadata to
restrict access on cubes satisfying speciﬁc characteristics.
In this paper we focused on the application of the LiMDAC
framework to simple access policies and queries. In future work,
we will look into handling more expressive access policies with
more than 3 search criteria, while we will cover also duplication is-
sues that arise when two contrary access policies are applied in the
same data. Furthermore, we plan to further investigate the prob-
lems of licensing and the terms of medical data reuse. In addition,
we will investigate issues that arise when creating and publishing
medical data as Linked Data. Last, we are planning to extend the
platform’s functionality (e.g., to enable data providers to create ac-
cess policies) as well as to beta test the platform with the help of
collaborating organizations.
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Appendix A
Table requirements related to availability constraints.No. RequirementsRequirements regarding the medical data
Access to medical data is restricted based on metadata about
medical data
1 The content of medical data e.g., data about cancer. The
content derives from the variables that have been
recorded for each subject in the clinical study2 The data provider of the medical data e.g., a hospital, a
pharmaceutical company or a health agency3 The clinical study from which medical data has beenAppendix A (continued)No. Requirements
derived
3a The title of the clinical study
3b The research topic of the clinical study e.g., children’s
obesity
3c The purpose of the clinical study e.g., for an
epidemiological study
3d The principal investigator of the clinical study
3e The health institution where the clinical study has been
conducted e.g., a clinical site, a hospital, a private
medical center, a clinical laboratory. It can also be
denoted as the creator of the clinical study3f The contributors of the clinical study if additional
subjects were needed3g The sponsor of the clinical study e.g., a pharmaceutical
company or a public health authority3h The period of time that the clinical study has been run
3i The location where the clinical study has been
conducted. This usually refers to the location of the
healthcare institute performed the clinical studyRequirements regarding the data consumer
Access is restricted based on metadata about the data consumer
13 The name of the data consumer
14 The location/origin of the data consumer e.g., a country
15 The research interest of the data consumer e.g.,
oncology or metabolic syndrome
16 The organization where the data consumer is working
16a The name of the organization
16b The type of the organization e.g., pharmaceutical
company
16c The location of the organization
16d The occupation/position in the organization that the
data consumer holds e.g., biologist, epidemiologist, or
endocrinologist17 The activity that the data consumer needs to perform. It
can also be denoted as the purpose of the data consumer17a The name of the activity/purpose
17b The type of the activity e.g., clinical trial,
epidemiological study, publication
17c The topic of the activity e.g., health habits, breast cancer
17d The role that the data provider plays during the activity
e.g., clinical researcher or data analystReferences
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